Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study
Wojciech Jurczak(Jagiellonian University), Ilídia Moreira(Instituto Português de Oncologia Francisco Gentil), Govind Babu Kanakasetty(Kidwai Memorial Institute of Oncology), Eduardo Munhoz(Hospital Erasto Gaertner), María Asunción Echeveste(Biogipuzkoa Health Research Institute), Pratyush Giri(Royal Adelaide Hospital), Nelson Castro(Hospital de Câncer de Barretos), Juliana Pereira(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Luiza Akria(Western Galilee Hospital), Sergey Alexeev(Institute of Oncology NN Petrov), Eugeniy Osmanov(Russian Cancer Research Center NN Blokhin), Peijuan Zhu(Princeton University), S. Alexandrova(Princeton University), Angela Zubel(Hexal (Germany)), Olof Harlin(Hexal (Germany)), Jutta Amersdorffer(Hexal (Germany))
Cited by 82Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis